MASIMO SET RADICAL 7 PULSE CO-OXIMETER by MASIMO CORPORATION

The Masimo SET® Radical 7 Pulse CO-Oximeter and accessories are indicated for the continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO2), pulse rate (measured by an SpO2 sensor), carboxyhemoglobin saturation (measured by an SpCO/SpMet sensor), and/or methemoglobin saturation (measured by an SpCO/SpMet sensor). The Masimo SET® Radical 7 Pulse CO-Oximeter and accessories are indicated for use with adult, pediatric, and neonatal patients during both no motion conditions, and for patients who are well or poorly perfused in hospitals, hospital-type facilities, mobile, and home environments. In addition, the Masimo SET® Radical 7 Pulse CO-Oximeter and accessories is indicated to provide the continuous noninvasive monitoring data obtained from the Masimo SET® Radical 7 Pulse CO-Oximeter and accessories of functional oxygen of arterial hemoglobin (SpO2) and pulse rate (measured by an SpO2 sensor) to multi-parameter devices for the display of those devices.

Device Description

The Masimo Rainbow SET® Radical 7 Pulse CO-Oximeter (Radical 7) with Rainbow technology is noninvasive monitoring of arterial oxygen saturation (%SpO2), pulse rate, carboxyhemoglobin saturation (%SpCO), and/or methemoglobin saturation (%SpMet). The Radical 7 features an LCD display that continuously displays numeric values for %SpO2 and pulse rate. Other information displayed by the Radical 7 include: %SpCO and/or %SpMet. Low Signal IQ (Low SIQ), Perfusion Index (PI), alarm status, alarm silence, battery life, sensor status, trends, and pleth waveform. The Radical 7 has output interfaces include: SatShare connection to multi-parameter monitors, Nurse Call analog output, and RS-232 serial output.

The Radical 7 is intended to be used with Masimo LNOP series of oximetery sensors, LNCS series of oximetery sensors, and patient cables. The Radical 7 is also intended to be used with Masimo Rainbow (SpCO/SpMet) sensors and Rainbow patient cables.

AI/ML Overview

Here's an analysis of the acceptance criteria and the studies that support the Masimo Rainbow SET® Radical 7 CO-Oximeter, based on the provided text:

Acceptance Criteria and Device Performance for Masimo Rainbow SET® Radical 7 CO-Oximeter

1. Table of Acceptance Criteria and Reported Device Performance

Parameter	Acceptance Criteria	Reported Device Performance
Oxygen Saturation (% SpO2) - No Motion
Adults, Pediatrics (70%-100%)	± 2 digits	70%-100% ± 2 digits
Neonates (70%-100%)	± 3 digits	70%-100% ± 3 digits
Oxygen Saturation (% SpO2) - Motion
Adults, Pediatrics (70%-100%)	± 3 digits	70%-100% ± 3 digits
Neonates (70%-100%)	± 3 digits	70%-100% ± 3 digits
Oxygen Saturation (% SpO2) - Low Perfusion
Adults, Pediatrics (70%-100%)	± 2 digits	70%-100% ± 2 digits
Neonates (70%-100%)	± 3 digits	70%-100% ± 3 digits
Carboxyhemoglobin Saturation (% SpCO)	± 3 digits (for 1%-40%)	1%-40% ± 3 digits
Methemoglobin Saturation (% SpMet)	± 1 digit (for 1%-15%)	1%-15% ± 1 digits
Pulse Rate (bpm) - No Motion	± 3 digits (for 25-240 bpm)	25 to 240 ± 3 digits
Pulse Rate (bpm) - Motion	± 5 digits (for 25-240 bpm)	25 to 240 ± 5 digits
Pulse Rate (bpm) - Low Perfusion	± 3 digits (for 25-240 bpm)	25 to 240 ± 3 digits
Non-clinical (Bench) Test (SpO2)	Same accuracy as simulator (± 2 digits)	Returned the same oxygen saturation accuracy values within ± 2 digits
Non-clinical (Bench) Test (Pulse Rate)	Same accuracy as simulator (± 3 digits)	Returned the same pulse rate values within ± 3 digits

Note: The "Acceptance Criteria" column is derived directly from the "Accuracy" section of the specifications, as the document states that the studies "validated" or "demonstrate" that the device meets these specified accuracies.

2. Sample Size Used for the Test Set and Data Provenance

SpO2 (No Motion, Motion, Neonates): The studies were conducted on "healthy adult volunteers" for non-neonatal cases and "human blood studies" for neonates (with a 1% added to account for fetal hemoglobin effects). The exact number of volunteers/patients or data points is not specified in the provided text.
SpO2 (Low Perfusion): Benchtop testing was used with a Biotek Index 2 simulator and a Masimo simulator. No human sample size is applicable for this specific test.
SpCO & SpMet: Validated in "human blood on healthy adult volunteers." The number of volunteers is not specified.
Data Provenance: The studies are described as "human blood studies on healthy adult volunteers" and "induced hypoxia studies." This suggests the data is prospective and likely collected for the purpose of this device validation. The country of origin is not explicitly stated, but given the FDA submission, it's presumed to be within the regulatory framework of the US.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications

The ground truth for all measurements (SpO2, SpCO, SpMet, Pulse Rate) was established using:

Laboratory CO-oximeter: This instrument served as the gold standard for comparing arterial blood samples.
ECG monitor: Used for pulse rate ground truth during some SpO2 studies.

The text does not specify the number of human experts used to establish the ground truth or their qualifications. The ground truth relied on accredited laboratory equipment rather than expert consensus on visual interpretation.

4. Adjudication Method for the Test Set

No information on adjudication method (e.g., 2+1, 3+1, none) is provided. The studies compared the device's readings directly against a laboratory CO-oximeter and ECG monitor, implying a direct comparison without a need for expert adjudication of conflicting readings.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

No MRMC comparative effectiveness study was done. The studies focused on the device's accuracy against a gold standard (laboratory CO-oximeter and ECG monitor), not on how human readers' performance might improve with or without AI assistance from the device.

6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study

Yes, standalone performance was evaluated. All the listed accuracy studies (for SpO2, SpCO, SpMet, and Pulse Rate under various conditions) represent the standalone performance of the device itself (the algorithm and sensor system) compared to the physiological ground truth. There is no mention of human-in-the-loop performance evaluation in the provided text.

7. Type of Ground Truth Used

SpO2, SpCO, SpMet: Established by measuring arterial blood samples with a laboratory CO-oximeter.
Pulse Rate: Established using an ECG monitor.

8. Sample Size for the Training Set

The document describes validation studies, but does not provide any information regarding a training set or its sample size. This suggests that if machine learning was used, the training data details were not included in this submission summary. The context implies a more traditional signal processing and calibration approach rather than a deep learning model requiring a distinct training and test set with explicit disclosure.

9. How the Ground Truth for the Training Set Was Established

As no training set is mentioned, no information is provided on how its ground truth would have been established.

Summary

{0}------------------------------------------------

JUL 2 7 2006

Submitted by:	Masimo Corporation40 ParkerIrvine, CA 92618(714) 297-7000FAX (714) 297-7001
Company Contact:	James J. Cronin, Vice President, Regulatory Affairs
Date Summary Prepared:	May 1, 2005
Trade Name	Masimo Rainbow SET® Radical 7 CO-Oximeter
Common Name	Pulse Oximeter and Sensor
Classification Name	Oximeter (74DQA)Transducer and Electrode Cable (including connector) (74DSA)Carbon monoxide test system (JKS)(862.3220)
Substantially Equivalent Devices	Masimo SET Rad-57cm and m Pulse CO-Oximeters510(k) Number -- K053477Masimo SET Radical Pulse Oximeter with SatShare™ and Accessories510(k) Number - K040214

Description of Masimo Rainbow SET® Radical 7 Pulse CO-Oximeter

{1}------------------------------------------------

Features and Benefits:

Clinically proven Masimo SETTM technology performance Applicable for use on neonate, infant, pediatric and adult patients Proven for accurate monitoring in no motion, and low perfusion environments Information display: %SpO2, pulse rate, %SpCO, and/or %SpMet, alarm, Perfusion Index, displays, Pleth waveform (SpO2 measurement), Trends, Low Signal IQ (SIQ), battery life FastSat™ (for SpO2 measurement) Three sensitivity levels - Max, Normal and APODTM (for SpO2 measurement) Adjustable averaging 2 to 16 seconds AC power or battery power (rechargeable batteries) Alarm limits for %SpO2, pulse rate, %SpCO, and/or %SpMet Audible Alarm for sensor-off and low battery 3D Alarm Adjustable alarm volume Trend memory of up to 30 days SatShare interface with multi-parameter monitors Nurse Call analog output Serial output to printers, PCs, and chart recorders Serial output to HP Vuelink Serial output to Spacelabs Universal Flexport Serial output to RadNet Serial output to RadLink

Intended use

Indications for use

Principles of Operation

SpO2 General Description

Pulse oximetry is a continuous and non-invasive method of measuring the level of arterial oxygen saturation in blood. The measurement is taken by placing a sensor on a patient, usually on the fingertip for adults, and the hand or foot for neonates. The sensor connects to the pulse oximetry instrument with a patient cable. The sensor collects signal data from the patient and sends it to the instrument. The instrument displays the calculated data in two ways: I ) as a percent value for arterial oxygen saturation (SpO2), and 2) as a pulse rate (PR).

{2}------------------------------------------------

SpCO And SpMet General Description

Pulse CO-oximetry is a continuous and non-invasive method of measuring the levels of carbon monoxide concentration (SpCO) and oxidized hemoglobin concentration (SpMet) in arterial blood. It relies on the same principles of pulse oximetry to make its SpCO/SpMet measurements are taken by placing a sensor on a patient, usually on the fingertip for adults. The sensor connects directly to the pulse CO oximetry instrument or with a patient cable. The sensor collects signal data from the patient and sends it to the instrument. The instrument displays the calculated data as percentage value for the SpCO and the SpMet. The Radical 7 is a combined SpO2, SpCO, and/or SpMet monitor with the same setup as that of a pulse oximeter and can display SpO2 in percentage values, pulse rate in beats per minute, SpCO in percentage values, and/or SpMet in percentage values.

Pulse oximetry is governed by the following principles:

Oxyhemoglobin (oxygenated blood), deoxyhemoglobin (non-oxygenated blood), carboxyhemoglobin 1. (blood with carbon monoxide content), and methemoglobin (blood with oxidized hemoglobin content) species differ in their absorption of visible and infrared light.
1. The amount of arterial blood in tissue changes with your pulse (photoplethysography). Therefore, the amount of light absorbed by the varying quantities of arterial blood changes as well.

The Radical 7 Pulse CO-Oximeter uses a multi-wavelength sensor to distinguish between oxygenated blood, deoxygenated blood, blood with carbon monoxide, and blood with oxidized hemoglobin content. Signal data is obtained by passing various visible and infrared lights (LED's, 400 to 1000nm) through a capillary bed (for example, a fingertip, a hand, a foot) and measuring changes in light absorption during the blood pulsatile cycle. The photodetector receives the light, converts it into an electronic signal and sends it to the Radical 7 for calculation.

Once the Radical 7 receives the signal from the sensor, it utilizes Masimo SET signal extraction technology to calculate the patient's functional oxygen saturation, fractional concentrations of carboxyhemoglobin and methemoglobin, and pulse rate. The SpCO and the SpMet measurements rely on multiwavelength calibration equations to estimate the percentages of carboxyhemoglobin and methemoglobin in arterial blood.

Method of Operation

The Masimo Rainbow SET® Radical 7 Pulse CO-Oximeter (Radical 7) is turned on. An oximetry sensor is attached to a patient's finger and one end of a patient cable is connected to the other end connected to the Radical 7 Pulse CO-Oximeter.

The monitor will begin continuously displaying the patient's pulse rate, and SpO2 value. If the Radical 7 is configured for SpCO and/or SpMet monitoring and the Rainbow sensor is attached to the patient's finger, then SpCO and/or SpMet values are also continuously displayed. The practitioner can then use the information that is continuously displayed on the monitor to help assess the condition of the patient and as an aide in determining if any intervention is required by the practitioner.

Once the practitioner determines the patient no longer requires monitoring, the cable is disconnected from the sensor, the CO-oximetry sensor is removed (and disposed of if it is a single use device), and the power to the monitor is turned off.

Power Source

The Masimo Rainbow SET® Radical 7 Pulse CO-Oximeter is operated on AC power or battery power.

Specifications and Operating Ranges

Oxygen Saturation (% SpO2) Carboxyhemoglobin Saturation (% SpCO)

1% - 100% 1-99%

{3}------------------------------------------------

Methemoglobin Saturation (% SpMet)	1-99.9%
Pulse Rate (bpm)	25-240
Perfusion	0.02% - 20%
Accuracy
Oxygen Saturation (% SpO2) - During No Motion Conditions
Adults, Pediatrics1	70%-100% ± 2 digits0% - 69% unspecified
Neonates2	70%-100% ± 3 digits0% - 69% unspecified
Oxygen Saturation (% SpO2) - During Motion Conditions3
Adults, Pediatrics	70%-100% ± 3 digits0% - 69% unspecified
Neonates	70%-100% ± 3 digits0% - 69% unspecified
Oxygen Saturation (%SpO2) - During Low Perfusion Conditions4
Adults, Pediatrics	70%-100% ± 2 digits
Neonates	70%-100% ± 3 digits
Carboxyhemoglobin Saturation (% SpCO)5	1%-40% ± 3 digits
Methemoglobin Saturation (% SpMet)5	1%-15% ± 1 digits
Pulse Rate (bpm) - During No Motion Conditions1
Adults, Pediatric, Neonates	25 to 240 ± 3 digits
Pulse Rate (bpm) - During Motion Conditions3
Adults, Pediatric, Neonates	25 to 240 ± 5 digits
Pulse Rate (bpm) - During Low Perfusion Conditions4
Adults, Pediatric, Neonates	25 to 240 ± 3 digits
Resolution
Oxygen Saturation (% SpO2)	1%
Carboxyhemoglobin Saturation (% SpCO), digital display	1%
Methemoglobin Saturation (% SpMet), digital display	0.1%
Pulse Rate (bpm)	1
Interfering Substances
Carboxyhemoglobin and methemoblobin may erroneously increase oxygen saturation readings.The level of increase is approximately equal to the amount of carboxyhemoglobin and/ormethemoglobin present. Dyes, or any substance containing dyes, that change usual arterialpigmentation may cause erroneous readings.
Power
AC Power	100 - 240 VAC, 47-63 Hz, 55VA
Rechargeable batteries	NiMH batteries
Isolation
Chassis Leakage Current	Less than 100 µAmp

{4}------------------------------------------------

Ground resistance

Less than 1.0 Ω

Environmental

Operating Temperature	41°F to + 104°F (5°C to +40°C)
Storage Temperature	-40°F to + 158°F (-40°C to +70°C)
Relative Humidity	5% to 95% noncondensing
Operating Altitude	500 mbar to 1060 mbar pressure-1,000 ft to 18,000 ft (-304 m to 5,486 m)

Circuitry

Microprocessor controlled Automatic self-test of oximeter when powered on Automatic setting of parameters Automatic alarm messages

Display

Type Data Displayed

LCD

SpO2 %, Pulse Rate, % SpCO and/or %SpMet, pleth waveform, alarm status, status messages, Signal IQ, perfusion index, sensor status, APOD, and FastSat

Audio indicators

Adjustable volume audible pulse: OFF and 25% to 100% in 4 steps Adjustable volume audible alarm tone: levels and 25% to 100% in 4 steps Alarm silence (120 seconds); all mute (continuous silence) Sensor condition alarms System failure and battery low alarms

Physical characteristics

Handheld Dimensions: Standalone Dimensions: Handheld Weight: Standalone Weight:

Modes

Averaging mode: Sensitivity

8.9" x 3.3" x 2.1" (22.6cm x 8.4cm x 5.3cm) 3.5" x 10.5" x 7.7" (8.9cm x 26.7cm x 19.6cm) 1.3 lbs (0.32 kg) 5.4 lbs (2.45 kg)

2, 4, 8, 10, 12, and 16 seconds Normal, APOD, and MAX

l The Masimo SET Technology with LNOP sensors has been validated for no motion accuracy in human blood studies on healthy adult volunteers in induced hypoxia studies in the range of 70-100% SpO2 against a laboratory CO-oximeter and ECG monitor.
The Masimo SET Technology with LNOP sensors has been validated for no motion accuracy in human 2 blood studies on healthy adult volunteers in induced hypoxia studies in the range of 70-100% SpO2 against a laboratory CO-oximeter and ECG monitor. 1% has been added to the saturation accuracy to account for the effects of fetal hemoglobin. This variation equals plus or minus one standard deviation, which encompasses 68% of the population.
3 The Masimo SET Technology with LNOP sensors has been validated for motion accuracy in human blood studies on healthy adult volunteers in induced hypoxia studies while performing rubbing and tapping motions, at 2 to 4 Hz at an amplitude of 1 to 2 cm and a non-repetitive motion between 1 to 5 Hz at an amplitude of 2 to 3 cm in induced hypoxia studies in the range of 70-100% SpO2 against a laboratory CO-oximeter and ECG monitor. 1% has been added to the saturation accuracy to account

Section 5, Page 5 of 7

{5}------------------------------------------------

for the effects of fetal hemoglobin. This variation equals plus or minus one standard deviation, which encompasses 68% of the population.

4 The Masimo SET Technology has been validated for low perfusion accuracy in bench top testing against a Biotek Index 2 simulator and a Masimo simulator with signal strengths of greater than 0.02% and a % transmission of greater than 5% for saturations ranging from 70 to 100%. This variation equals plus or minus one standard deviation which encompasses 68% of the population.
5 The Masimo SET Rainbow Technology with Rainbow DC-dc sensors have been validated in human blood on healthy adult volunteers against a laboratory CO-oximeter from 1-40% for carboxyhemoglobin and 1-15% for methemoglobin. This variation equals plus or minus one standard deviation which encompasses 68% of the population.

Environmental Testing

Applicable environmental testing per the Reviewers Guidance for Premarket Submissions - November 1993, i.e. electrical, mechanical and environmental were performed and all tests passed.

Biocompatibility Testing

All patient contact materials were tested as Surface Devices with skin contact for prolonged contact duration (>24 hr to 30 days) as defined ISO-10993-1: 1992 Biological Evaluation of Medical Devices - Part 1: Guidance on Selection of Tests. All patient contacting material passed.

Nonclinical tests performed that support a determination of substantial equivalence.

The Masimo Rainbow SET® Radical 7 Pulse CO-Oximeter and accessories was subjected to bench testing using a simulator that determined the performance accuracy of the instruments against the simulator under the range of oxygen saturation and pulse rates that the device specify.

The results of the bench testing showed that the Masimo Rainbow SET® Radical 7 Pulse CO-Oximeter and accessories returned the same oxygen saturation accuracy values within ± 2 digits and pulse rate values within ± 3 digits, under no motion condition, when compared to the simulators used.

Clinical tests performed that support a determination of substantial equivalence.

Clinical studies were performed using the Masimo Rainbow SET® Radial 7 Pulse CO-Oximeter on healthy adult volunteer subjects during no motion conditions who were subjected to a progressive induced hypoxia and measuring the arterial hemoglobin saturation value with the instruments against the arterial hemoglobin oxygen determined from arterial blood samples with a CO-Oximeter.

The Masimo SET Rainbow Technology with Rainbow DC-dc sensors have been validated in human blood on healthy adult volunteers against a laboratory CO-oximeter from 1-40% for carboxyhemoglobin and 1-15% for methemoglobin. This variation equals plus or minus one standard deviation which encompasses 68% of the population.

Conclusions

The results of the environmental testing demonstrate that the Masimo Rainbow SET® Radical 7 Pulse CO-Oximeter and accessories met the requirements of Reviewers Guidance for Premarket Submissions - November 1993.

The results of the biocompatibility testing demonstrates the all patient contacting material met the requirements of ISO-10993-1: 1992 Biological Evaluation of Medical Devices - Part 1: Guidance on Selection of Tests for Surface Devices with skin contact for prolonged contact duration (>24 hr to 30 days).

Section 5, Page 6 of 7

{6}------------------------------------------------

The results of the bench testing demonstrate that the Masimo Rainbow SET® Radical 7 Pulse CO-Oximeter meets their performance requirements.

The results of the clinical testing demonstrate that the Masimo Rainbow SET® Radical 7 Pulse CO-Oximeter and accessories meet their performance requirements during no motion and motion conditions.

The non-clinical and clinical testing performed demonstrates that the Masimo Rainbow SET® Radical 7 Pulse CO-Oximeter and accessories are safe, effective, and performs as well as the predicate devices, the Masimo SET Rad-57cm and m Pulse CO-Oximeters (K053477) and the Masimo SET® Radical Pulse Oximeter (K040214). Therefore, the Masimo SET® Radical 7 Pulse CO-Oximeter and accessories are substantially equivalent to the mentioned predicate devices.

{7}------------------------------------------------

Image /page/7/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of four human profiles facing to the right, stacked on top of each other.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JUL 27 2006

Mr. James J. Cronin Vice President. Regulatory Affairs Masimo Corporation 40 Parker Irvine, California 92618

Re: K061204

Trade/Device Name: Masimo SET® Radical 7 Pulse CO-Oximeter Regulation Number: 21 CFR 870,2700 Regulation Name: Oximeter Regulatory Class: II Product Code: DQA, JKS and DPZ Dated: May 1, 2006 Received: May 9, 2006

Dear Mr. Cronin:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice. labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{8}------------------------------------------------

Page 2 - Mr. Cronin

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-frec number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Chiu-Ling, Ph.D.

Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{9}------------------------------------------------

Section 4 - Indications for Use

510(k) Number (if known):

Device Name: Masimo SET Radical 7 CO-Oximeter

Indications For Use:

The Masimo SET® Radical 7 Pulse CO-Oximeter and accessories are indicated for the continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO2), pulse rate (measured by an SpO2 sensor), carboxyhemoglobin (measured by an SpCO/SpMet sensor), and/or methemoglobin saturation (measured by an SpCO/SpMet sensor). The Masimo SET® Radical 7 Pulse CO-Oximeter and accessories are indicated for use with adult, pediatric, and neonatal patients during both no motion and motion conditions, and for patients who are well or poorly perfused in hospital-type facilities, mobile, and home environments. In addition, the Masimo SET® Radical 7 Pulse CO-Oximeter and accessories is indicated to provide the continuous nonitoring data obtained from the Masimo SET® Radical 7 Pulse CO-Oximeter and accessories of functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate (measured by an SpO2 sensor) to multi-parameter devices for the display of those devices.

Prescription Use X

AND/OR

Over-The-Counter Use

(Per 21 CFR 801 Subpart D)

(Per 21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Aura Milionn
-Sion-Sill

n of Anesthesiology, General Hospital Jon Control, Dental Devic

Regulation Number and Section

§ 870.2700 Oximeter.

(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).